Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | DUT | P33316 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5473563 | 0.88 | SKP2 (0.49) | ALDH1A1TDP1SKP2CYP3A4DUT | |
| SCHEMBL2865322 | 0.84 | ALDH1A1 (0.37) | ALDH1A1TDP1CASP1SKP2PARP1 | |
| SCHEMBL19557809 | 0.82 | GAA (0.53) | ALDH1A1PARP1CYP3A4KDM4EMAPT | |
| SCHEMBL2366928 | 0.79 | GFER (0.45) | ALDH1A1TDP1CYP3A4DUTSMN1; SMN2 | |
| SCHEMBL5469399 | 0.78 | ALDH1A1 (0.41) | ALDH1A1TDP1CASP1DUTSMN1; SMN2 | |
| SCHEMBL12191687 | 0.78 | ALDH1A1 (0.45) | ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT | |
| SCHEMBL2696466 | 0.77 | CYP1A2 (0.41) | DUTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL4430490 | 0.76 | ALDH1A1 (0.41) | ALDH1A1TDP1CYP3A4KDM4ESMN1; SMN2 | |
| SCHEMBL24197444 | 0.76 | TAAR1 (0.44) | ALDH1A1TDP1KDM4ESMN1; SMN2KMT2A | |
| SCHEMBL8136096 | 0.75 | ALOX5AP (0.36) | SKP2DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9809668-B2 | Polymerizable compound, composition, polymer, optically anisotropic body, liquid crystal display device, and organic EL device | DIC CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-20170002123-A1 | POLYMERIZABLE COMPOUND, COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, LIQUID CRYSTAL DISPLAY DEVICE, AND ORGANIC EL DEVICE | DIC CORPORATION (JP) | 2017-01-05 | — | — | US | disclosed |
| EP-2132184-A1 | NOVEL PYRIMIDINE DERIVATIVES 698 | AstraZeneca AB (SE) | 2009-12-16 | — | — | EP | disclosed |
| WO-2008104754-A1 | NOVEL PYRIMIDINE DERIVATIVES 698 | ASTRAZENECA AB (SE) | 2008-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170002123-A1 | POLYMERIZABLE COMPOUND, COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, LIQUID CRYSTAL DISPLAY DEVICE, AND ORGANIC EL DEVICE | OCIAD1, OCIAD2, ELOC | ALDH1A1 3129/4885TDP1 2564/4885CASP1 2291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.